Altus Biologics Inc., Cambridge, Mass., said it has raised $35 million in private financing. Nomura International and U.S. Venture Partners were the lead investors, joined by BankInvest and ...

Altus Biologics Inc., a Cambridge biotech company, has sold the European marketing rights of a drug it is developing to help treat cystic fibrosis patients. A German pharmaceutical company ...

Specialized implant manufacturer ChoiceSpine was acquired by Altus Capital Partners ... interbody and lateral implants, as well as biologics kits. “ChoiceSpine, a global medical device ...

As Vice President of Biologics, Bishop will lead and be responsible ... TN and is privately held by Altus Capital Partners. The company prides itself on providing excellent products and ...